ArticleGland surgery2026
Comparable long-term survival outcomes after lobectomy versus total thyroidectomy treatment of minimal extrathyroidal extension differentiated thyroid cancer patients.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Differentiated thyroid cancer (DTC) patients (tumor size ≤4 cm) with minimal extrathyroidal extension (MEE), which was used to be classified as T3 disease, now are classified as T1/T2 disease according to the largest tumor size. However, few studies explored the survival difference between DTC patients with MEE who received lobectomy or total thyroidectomy treatment. We aimed to compare the long-term survival rate of DTC patients with MEE after total thyroidectomy and lobectomy by using the national cancer registration data. Methods: We performed a retrospective cohort analysis to examine the long-term survival outcomes after lobectomy versus total thyroidectomy treatment of DTC patients with MEE using the univariate and multivariate survival analysis. Results: Of 1,889 included DTC patients with MEE, 113 patients (6.0%) received lobectomy and 1,776 patients (94.0%) received total thyroidectomy. DTC patients with MEE who underwent lobectomy experienced a similar cancer-specific survival (CSS) rate compared with those who underwent total thyroidectomy (10-year CSS rate: 99.1% Conclusions: pT1/pT2 DTC patients with MEE who underwent lobectomy or total thyroidectomy have excellent comparable survival outcomes, which supports the increased use of lobectomy in the treatment of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.